Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation

Journal of the National Cancer Institute

Volumn 84, Issue 11, 1992, Pages 883-887

  Visakorpi, Tapio ^a   Kallioniemi, Olli P ^b   Heikkinen, Asko ^c   Koivula, Timo ^a   Isola, Jorma ^d  

^a Department of Chemistry ^*  (Finland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Hospital of Valkeakoski ^*  (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RESEARCH; CANCER SURVIVAL; CELL GROWTH; CLINICAL ARTICLE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN ANALYSIS; REGULATORY MECHANISM;

AGED; ANTIBODIES; DNA, NEOPLASM; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GENES, P53; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MUTATION; NUCLEAR PROTEINS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN P53; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0026651717     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/84.11.883     Document Type: Article

References (18)

1. Carter BS, Ewing CM, Ward WS, ET AL: Allelic loss of chromosomes 16q and l0q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755, 1990
2. Bookstein R, Rio P, Madreperla SA, ET AL: Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci USA 87:7762-7766, 1990
3. Bookstein R, Shew JY, Chen PL, ET AL: Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247:712-715, 1990
4. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 351:453-456, 1991
5. Lane DP, Benchimol S: P53: Oncogene or anti-oncogene? Genes Dev 4:1-8, 1990
6. Rodrigues NR, Rowan A, Smith ME, ET AL: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87:7555-7559, 1990
7. Davidoff AM, Humphrey PA, Iglehart JD, ET AL: Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci USA 88:5006-5010, 1991
8. Hollstein M, Sldransky D, Vogelstein B, ET AL: p53 mutations in human cancers. Science 253:49-53, 1991
9. International Union Against Cancer: TNM. Classification of malignant tumours, 4th ed. Berlin: Springer-Verlag, 1987
10. Visakorpi T, Kallioniemi OP, Paronen IY, ET AL: Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: Implications for prognosis and response to endocrine therapy. Br J Cancer 64:578-582, 1991
11. Mostofi FK: Histological typing of prostate tumours. Geneva: WHO, 1980
12. Banks L, Matlashewski G, Crawford L: Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 159:529-534, 1986
13. Hedley DW, Fredlander ML, Taylor IW, ET AL: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31:1333-1335, 1983
14. Kallioniemi OP: Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intrarumor heterogeneity. Cytometry 9:164-169, 1988
15. Kallioniemi OP, Visakorpi T, Holli K, ET AL: Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. Cytometry 12:413-421, 1991
16. Dixon WJ: BMDP Statistical Software. Berkley, Los Angeles, and London: Univ Calif Press, 1981
17. Rubin SJ, Hallahan DE, Ashman CR, ET AL: TWO prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes. J Surg Oncol 46:31-36, 1991
18. Barter J, Bartkova J, Vojtesek B, ET AL: Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int J Cancer 46:839-844, 1990